AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net buying: insiders sold $0 and bought $335K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$335K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $18.61
- 52-wk high
- $51.34
- High
- $18.87
- 52-wk low
- $18.02
- Low
- $18.16
- Prev close
- $18.63
- Mkt cap
- $1.03B
- P/E
- 30.5x
- Volume
- 1.48M
- Fwd P/E
- 27.3x
- Beta
- 1.17
- P/S
- 1.2x
- P/B
- 3.3x
- Profit margin
- +3.9%
- Op margin
- +2.0%
- ROE
- +10.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about UTI filings
Are insiders buying or selling Universal Technical Institute Inc (UTI) stock?
Net buying: insiders sold $0 and bought $335K of UTI stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Devincenzi, Robert Thomas (Director), who bought $335K. The latest filing was on Sep 30, 2026.
Which members of Congress have traded UTI recently?
None. No member of Congress disclosed a UTI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this UTI smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (2)
- BR
BlackRock
$192.3M
added
- SS
State Street
$43.4M
added
What insiders are doing
Buys (3)
- DR
Devincenzi Robert Thomas
$20K
bought
- DR
Devincenzi Robert Thomas
$20K
bought
- DR
Devincenzi Robert Thomas
$22K
bought
How top traders are positioned
No tracked top-trader positions in UTI right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in $0.03 a share above what analysts expected.
Earnings per share
$0.01 expected
Reports Nov 18, 2026, in 48 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $222.4M | $220.8M | $221.4M | $218.9M |
| Cost of what it sold | $111.7M | $110.4M | $118.0M | $118.3M |
| Gross profit | $110.8M | $110.4M | $103.4M | $218.9M |
| What it spent | ||||
| Sales and admin | $64.5M | $69.5M | $72.2M | $71.2M |
| Other operating costs | $21.3M | $25.2M | $30.9M | $144.5M |
| Total operating expenses | $85.8M | $94.7M | $103.1M | $215.7M |
| What was left | ||||
| Operating profit | $25.0M | $15.7M | $339.0K | $3.2M |
| Interest on debt | $909.0K | $971.0K | $1.1M | $1.0M |
| Profit before tax | $25.6M | $16.2M | $383.0K | $3.1M |
| Tax | $6.8M | $3.4M | -$50.0K | $820.0K |
| Net profit | $18.8M | $12.8M | $433.0K | $2.3M |
| EBITDA | $35.0M | $32.5M | $16.0M | $21.2M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Macro
10 macro signals shaping UTI right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results